Position in BTAI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$346,274
+$288,771 QoQ
Shares Held
245,585
+472.3% QoQ
Ownership
0.784%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#4
of 47 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BTAI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Oaktree Fund Advisors, LLC holds $626,798 across 2 Drug Manufacturers - Specialty & Generic names. BTAI ranks #1 (55.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BTAI |
BioXcel Therapeutics, Inc.
This page
|
245,585 | $346,274 | |
| 2 | ALVO |
Alvotech
|
76,023 | $280,524 |
All Filings in BTAI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $346,274 | 245,585 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $57,503 | 42,913 | Shares | Defined | 2026-05-20 | |
| 2025-12-31 | $68,660 | 42,913 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $109,857 | 42,913 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $77,672 | 42,913 | Shares | Defined | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||